Hims & Hers Shares Rise as RFK Jr. Comments on Peptide Regulation Changes
Hims & Hers (HIMS) shares rose as much as 11% in premarket trading following comments from HHS Secretary Robert F. Kennedy Jr. about the FDA seeking to remove 12 peptides from Category 2 restrictions. The stock had already gained around 14% the previous day, indicating continued positive momentum.
Tickers: $HIMS
Topics: FDA regulations HHS Secretary Hims & Hers stock price movement